Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma : updated analysis of CASTOR

DSpace Repository

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma : updated analysis of CASTOR

Author: Spencer, Andrew; Lentzsch, Suzanne; Weisel, Katja; Avet-Loiseau, Herve; Mark, Tomer M.; Spicka, Ivan; Masszi, Tamas; Lauri, Birgitta; Levin, Mark-David; Bosi, Alberto; Hungria, Vania; Cavo, Michele; Lee, Je-Jung; Nooka, Ajay K.; Quach, Hang; Lee, Cindy; Barreto, Wolney; Corradini, Paolo; Min, Chang-Ki; Scott, Emma C.; Chanan-Khan, Asher A.; Horvath, Noemi; Capra, Marcelo; Beksac, Meral; Ovilla, Roberto; Jo, Jae-Cheol; Shin, Ho-Jin; Sonneveld, Pieter; Soong, David; Casneuf, Tineke; Chiu, Christopher; Amin, Himal; Qi, Ming; Thiyagarajah, Piruntha; Sasser, A. Kate; Schecter, Jordan M.; Mateos, Maria-Victoria
Tübinger Autor(en):
Weisel, Katja
Published in: Haematologica (2018), Bd. 103, H. 12, S. 2079-2087
Verlagsangabe: Ferrata Storti Foundation
Language: English
Full text: http://dx.doi.org/10.3324/haematol.2018.194118
ISSN: 0390-6078
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)